#Tubeless Insulin Pumps Market Analysis in Developed Countries

[sambilling]

Insulin Pump Manufacturers - Segmented Based on Markets

Insulin Pump Manufacturers - Segmented Based on Markets

The insulin pump market is experiencing rapid growth due to new technology, improved sensitivity and increased functionality. Presently, insulin pump market is dominated by generic and small-scale insulin pump companies, but it is anticipated that number will gradually come down as competition increases. The market analysis presented in this article presents the latest information on insulin pump market, including the current status of insulin pump technology, key drivers, key issues and opportunities, and outlook for the market. Insulin Pump Market Report classifies the global health and safety products breakdown by manufacturer, type, product and application, and studies the competitive landscape by region, technology, applications and challenges.

The insulin pump market category is broadly classified into five segments based on product specifications, geographical location, application and target customers. A comprehensive insulin pump market report can provide insights about each of these key drivers. The first segment presents data on the leading insulin pump manufacturers based on the product specifications and market share analysis. Data on the top insulin pump manufacturers are presented by product type, offering an overview of leading insulin pump type. Data on key vendors are presented by application and target customers, which provide a comprehensive overview of insulin pump type applications.

The insulin pump market is segmented into four segments based on technological developments. Based on this segmentation, the insulin pump market can be further segmented based on the insulin pump technology implemented. The insulin pump market research report classifies the insulin pump technology based on the results of the current and ongoing research methodology. Data on the insulin pump market can be categorized into current technologies, emerging technologies, and future technologies. Research methodology data are presented to provide insights on the trends and development in the insulin pump market.

One of the most critical categories of insulin pump market examined is Accu-Check. Based on the analysis conducted on Accu-Check's customer satisfaction survey, Accu-Chek have won the preference of most of the insulin pump users based on its extensive user support, extended warranties and extended product life span. Most of the feedback from the users indicated that Accu-Check is easy to use and reliable.

Another important category in insulin pump market research to the company named Ascential. Ascential offers two types of insulin pumps based on its specifications. The first one is based on the glucose monitor technology and delivers insulin when the sensor device senses glucose levels. The second one is based on the Accu-Chek brand and delivers insulin directly to the body when it detects the absence of glucose in the body's blood stream. Based on the recent study conducted by the National Diabetes Education Program, this technology is said to deliver insulin more quickly and consistently than the previous technology.

The insulin pump market is further segmented based on its applications. The insulin pump used by the patient is segmented into different categories like insulin pump for insulin and glucose monitoring, insulin pump for insulin and food replacement insulin pump among many other applications. Insulin pumps with glucose monitors are further divided into two categories; based on the glucose monitors that delivers insulin automatically, and those that deliver insulin through oral administration. Lastly, the insulin pump market is further segmented based on the technologies that are applied to each application.

In terms of the insulin pump market in Asia and Latin America, there are three manufacturers that dominate the segment. These companies are Ameda, Sanofi Aventis and Novartis. The manufacturer in Asia and Latin America that has the highest number of product lines is Cipla.

There are many government initiatives in Asia and Latin America that have resulted in the increased production of insulin pump to cater to the growing need of diabetes management devices in such countries. This has further prompted companies to focus more on the insulin pump market in developing countries. These initiatives have helped the industry to develop and produce more efficient insulin products for the diabetes management devices and patients.

Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Tubeless Insulin Pump market in this environment. In terms of revenue, this research report indicated that the global Tubeless Insulin Pump market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Tubeless Insulin Pump industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The ???Insulet Corporation aims at producing XX Tubeless Insulin Pump in 2020, with XX % production to take place in global market, ????Johnson & Johnson accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Tubeless Insulin Pump Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Tubeless Insulin Pump Market? Insulet Corporation Johnson & Johnson Medtrum Technologies Roche Holding AG Cellnovo Group Spring Health Solution Debiotech CeQur SA Valeritas Abbott Diabetes Care ... Major Type of Tubeless Insulin Pump Covered in XYZResearch report: Pod/Patch Remote Others Application Segments Covered in XYZResearch Market Hospitals Pharmacies e-Commerce Others For any other requirements, please feel free to contact us and we will provide you customized report.

For more details contact as https://www.reportmines.com/contact-us.php

[marketreserchnews]

Tubeless Insulin Pump Market is Impressive Massive Growth |

Tubeless Insulin Pump Market with data Tables for historical and forecast years represented with Chats & Graphs spread through 250 Pages with easy to understand detailed analysis. The study highlights detailed assessment of the Market and display market sizing trend by revenue & volume (if applicable), current growth factors, facts, expert opinions and industry validated market development data. The major players covered in the tubeless insulin pump market report are Insulet Corporation., F. Hoffmann-La Roche Ltd, Debiotech S.A, CeQur, Valeritas, Inc., Tandem Diabetes Care, Inc., Animas, Medtrum Technologies, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Tubeless insulin pump market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 3842.57 million by 2027 growing at a CAGR of 24.12% in the above-mentioned forecast period.

Get FREE Sample Report + All Related Graphs & Charts Here@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-Tubeless Insulin Pump-market

By Component (Pod/Patch, Remote, Accessories), Distribution Channel (Hospitals, Pharmacies, E- Commerce), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa)

Technological advancement in the insulin pumps is expected to enhance the market growth. Some of the other factors such as increasing government funding for the study of various diseases, rising prevalence of obesity, rising awareness about the injuries & infections caused by traditional invasive insulin pumps, growing ageing population, and increasing approvals for treatment & devices is also expected to drive the tubeless insulin pump market in the forecast period of 2020 to 2027.

Table of Contents:-

Tubeless Insulin Pump Market Overview

Company Profiles

Global Tubeless Insulin Pump Market Competition, by Players

Global Tubeless Insulin Pump Market Size by Regions

North America Tubeless Insulin Pump Revenue by Countries

Europe Tubeless Insulin Pump Revenue by Countries

Asia-Pacific Tubeless Insulin Pump Revenue by Countries

South America Tubeless Insulin Pump Revenue by Countries

The Middle East and Africa Revenue Tubeless Insulin Pump by Countries

Global Tubeless Insulin Pump Market Segment by Type

Global Tubeless Insulin Pump Market Segment by Application

Research Findings and Conclusion

Appendix

FREE Table of Contents Is Available here@ https://www.databridgemarketresearch.com/toc/?dbmr=global-Tubeless Insulin Pump-market

Highlights of the worldwide Cloud Robotics Market Report:

Imperative alteration of the market dynamics

Broad-gauge analysis of the parent market

Market share study

Estimate the role of business growth and advancement

Current, historic, and future research in terms of importance and volume

Main strategies of the foremost important players

In order to better analyze value chain/ supply chain of the Industry, a lot of attention given to backward & forward Integration

– Tubeless Insulin Pump Manufacturers

– Tubeless Insulin Pump Distributors/Traders/Wholesalers

– Tubeless Insulin Pump Sub-component Manufacturers

– Industry Association

– Downstream Vendors

Reasons to access this Report:

Get to know opportunities and plan strategies by having a strong understanding of the investment opportunities in the Tubeless Insulin Pump Market

Facilitate decision-making based on strong historic and forecast data

Develop strategies based on the latest reports.

Identification of key parameter driving investment opportunities in the Tubeless Insulin Pump Market

Identify key partners and business development avenues

Respond to your competitors' business structure, strategy and prospects

Identify key strengths and weaknesses of important market participants

Position yourself to gain the maximum advantage of the industry's growth potential

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

Buy now @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-Tubeless Insulin Pump-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[aleemtbrc]

Global Insulin Pens, Syringes, Pumps And Injectors Market Is Expected to Grow at Robust Pace By 2022

TheBusinessResearchCompany published its Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global insulin pens, syringes, pumps and injectors market. The report covers the insulin pens, syringes, pumps and injectors market’s segments- pens, injectors and pumps, syringes,  hospitals, homecare, reusable, disposable, tubed pumps, and tubeless pumps.

Explore Complete Report https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 50+ geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Request to get the sample of this report https://www.thebusinessresearchcompany.com/sample.aspx?id=2461&type=smp

Many companies are focusing on technological advancements in insulin delivery systems to deliver insulin effectively and safely. For instance, on June 2018, the US Food and Drug Administration approved the MiniMed 670G hybrid closed looped system. Similarly, on February 2019, FDA also approved Tandem Diabetes Care t: Slim X2 insulin pump. These devices contain automated insulin dosing systems, continuous glucose monitors, blood glucose meters, and other helpful applications.

Get Discount On This Report https://www.thebusinessresearchcompany.com/sample.aspx?id=2461&type=discount

Chapters from Table of Content:

Chapter 1. Executive Summary

Chapter 2. Insulin Pens, Syringes, Pumps And Injectors Market Characteristics

Chapter 3. Insulin Pens, Syringes, Pumps And Injectors Market Size And Growth

Chapter 4. Insulin Pens, Syringes, Pumps And Injectors Market Segmentation

Chapter 5. Insulin Pens, Syringes, Pumps And Injectors Market Regional And Country Analysis

…….

Chapter 27. Insulin Pens, Syringes, Pumps And Injectors Market Trends And Strategies

Chapter 28. Insulin Pens, Syringes, Pumps And Injectors Market Future Outlook and Potential Analysis

Chapter 29. Appendix

Few Points From List of Tables:

Table 1: Global Historic Market Growth, 2014-2018, $ Billion

Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion

Table 3: Global Insulin Pens, Syringes, Pumps And Injectors Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

………..

Table 49:  Medtronic plc (Ireland) Financial Performance

Table 50: Abbott Financial Performance

Table 51: Insulet Corporation (US) Financial Performance

Check our blog for more information at http://blog.tbrc.info/

About Us:

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

[rajputdishank20-blog]

Rapid Influenza Diagnostic Test Market By Product Types, By Patient Types, By End-Users And Regions – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast 2020 – 2026

The global rapid influenza diagnostic tests market is expected to expand with substantial CAGR during the forecast period, 2020 – 2026. The growth of the market is attributed to the increasing incidence of chronic diseases and influenza, rising government initiatives, high R&D investments, increasing awareness about influenza, and growing geriatric population.

Rapid influenza diagnostic tests (RIDTs) are immunoassays which identifies the presence of influenza and B viral nucleoprotein antigens in respiratory specimen. Influenza is a communicable disease which spreads from person to person via air when infected person coughs or sneezes. Rapid diagnostic tests provide rapid and accurate diagnosis of influenza infection. These tests are more often used as point-of-care testing due to several advantages such as ease of use, high specificity, and rapidly results in less than approximately 15 minutes.

Market Trends, Drivers, Restraints, and Opportunities:

Increasing prevalence of influenza and chronic disorders such as cardiovascular diseases and rising government initiatives to counter the increasing influenza outbreaks are key drivers boosting the market.

High specificity and less time taken by rapid influenza diagnostic tests and rising investment in detection and control of influenza are propelling the market growth.

Rising awareness about influenza an enhancing geriatric population is boosting the market.

Exponential growth in healthcare expenditure by developing countries, enhancing healthcare quality, and high R&D investments by pharmaceutical companies are fueling the market growth.

Variability in sensitivity and specificity in diagnostic tests and negative results of RIDTs for a tubeless insulin pump are major restrains of the market.

High prices of reagents and kits is a restricting factor of the market growth.

Lack of skilled medical professional and unfavorable regulatory framework are hindering the market growth.

Emerging advanced RIDTs in market is expected to create opportunities for expansion of the market.

Read More: https://dataintelo.com/report/rapid-influenza-diagnostic-test-global-market/

[rohinic123-blog]

Tubeless Insulin Pumps Market Demand, Insights and Forecast up to 2027

Global Tubeless Insulin Pumps Market: Snapshot

The diabetes care industry has made continuous strides. An array of insulin pump technologies with better management of hyperglycemia and hypoglycemia episodes and improved patient comfort has been unveiled over the past several years. Broadly, the evolution of the demand for these insulin pumps, notably tubeless pumps, has been guided by changing regulatory landscape, and evidently constant technological advancements. Particularly, advances in continuous insulin delivery systems including the automation of them has unlocked undoubtedly incredible prospects. The tubeless insulin pumps market has seen new growth trajectories from relentless efforts by medical device makers to expand the choice for patients. Fast evolving demand for smart insulin pumps in developed countries has opened new avenues in other regions.

Report Overview @ https://www.transparencymarketresearch.com/tubeless-insulin-pumps-market.html

The advent of interoperable automated insulin delivery (AID) system has unarguably expanded the potential of tubeless insulin pumps market. The integration of tubeless insulin pumps with wireless technology has helped in expanding the choice for patient populations in how they want to manage the disease. Integration with automated insulin dosing software has made these pumps more digitally connected.

Planning To Lay Down Future Strategy? Request Brochure Of Tubeless Insulin Pumps Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73899

Global Tubeless Insulin Pumps Market: Growth Dynamics

The demands in tubeless insulin pumps market has thrived on the back of a conscious and steady shift of patients from traditional insulin delivery devices to modern devices with integrated and automated pumps technology. Over the years, in numerous developed nations, especially in North America and Europe, discreet insulin delivery devices have hit the market, and are expected to gather traction in the coming few years. Equipping these devices with smart glucose meters has also bolstered the functionality of tubeless insulin pumps market. Medical device makers are increasingly focusing on the patients’ convenience aspect to launch new products in the tubeless insulin pumps market.

Growing adoption of connected digital diabetes management platform will raise patients’ expectations even higher in the coming few years. Making these devices more secure will then become imperative. In recent years, a few novel product launches have been made in the tubeless insulin pumps market. Many medical devices companies in tubeless technologies have seemingly benefited from user-centered design approach. In future, glucose-responsive insulin approaches will pave way to cutting-edge technologies in tubeless insulin pumps market.

To Obtain All-Inclusive Information On Forecast Analysis Of Tubeless Insulin Pumps Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=73899

Global Tubeless Insulin Pumps Market: Notable Developments

A Massachusetts-based company Insulet Corporation has been seeking to introduce smart insulin management system for diabetes care. To this end, the company announced recently in 2019 that it has been successful in getting the U.S. FDA clearance to sell its insulin management system, the Omnipod DASH, as an integrated insulin pump. Encouraged by this, the medical device makers has unveiled alternate controller enabled infusion pump (ACE Pump), Omnipod DASH System, which is designed to infuse drugs to patients at set or variable rate. The device has been integrated with external devices via secure connections. The maker has asserted that the clearance proves that it has adhered to accuracy, cybersecurity, and clinical relevance as put forth by the U.S. FDA. The company opines that launch of devices such as Omnipod DASH Systeme will further the spirit of innovations in the tubeless insulin pumps market.

More Trending Reports by Transparency Market Research –

Insulin Delivery Devices Market –

https://www.globenewswire.com/news-release/2019/02/26/1742304/0/en/Insulin-Delivery-Devices-Market-is-rising-to-a-valuation-of-US-20-9-billion-by-2025-Says-TMR.html

Medical Electrode Market –

https://www.globenewswire.com/news-release/2019/02/28/1744453/0/en/Medical-Electrode-Market-to-reach-US-857-million-by-2022-Due-To-Expansion-in-Cardiology-Diseases-Globally-TMR.html

Request For Coronavirus Infection Market Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16940

[market-research-future]

Blood Glucose Test Strip Market Insights | Dynamics and Growth | Forecast To 2020

Market Research Future Published a Cooked Research Report on “Blood Glucose Test Strip Market Research Report- Global Forecast till 2020” Market Analysis, Scope, Stake, Progress and Trends.

Blood Glucose Test Strip Market Trends, Growth And Share Analysis By Technology (Thick Film Electrochemical, Thin Film Electrochemical, Optical) - Global Forecast Till 2020

Market Scenario

The blood glucose test strip market size is presumed to garner USD 18.5 billion during the forecast period (2015-2020). The market is presumed to register 6.2 % CAGR owing to the increasing diabetic population, asserts Market Research Future (MRFR). Blood glucose test strip can be referred to as a small non-reusable plastic strip. It is a crucial component of blood glucose meters that helps to monitor and control diabetes.

Drivers and Constraints Impacting the Market

Blood glucose test strips are self-testing strips which let pre-diabetic and diabetic people track their blood glucose level on a regular basis without visiting a diagnostic laboratory or a clinic. With the growing diabetic population, the global market for blood glucose test strip is considered to foster during the assessment period. For instance, as per the International Diabetic Federation, around 415 million people had diabetes in 2015. The number is estimated to reach 642 million by the end of 2040. Moreover, technological advancements such as accuracy of the tests along with awareness among the people regarding diabetes are stimulating the market growth.

On the flip side, product recall owing to the inefficiency of devices such as intense competition resulting in pricing pressure and false glucose reading are some of the major factors considered to impede the global blood glucose test strip market in the coming years.

Global Blood Glucose Test Strip Market: Segmental Analysis

The blood glucose test strip market has been segmented based on technology, distribution channel, and region.

By mode of technology, the global blood glucose test strip market has been segmented into optical, thin film electrochemical, and thick film electrochemical.

By mode of distribution channel, the global blood glucose test strip market has been segmented into retail pharmacy and hospital pharmacy. Among these, the hospital pharmacy is likely to dominate the global market and is anticipated to maintain its dominance over the assessment period. The growth is attributed to the increasing preference for self-care testing among the patients to monitor diabetes. Regional Insights

Geographically, the global blood glucose test strip market span across regions namely, North America, Europe, Asia Pacific, and the Middle East and Africa.

Among all the regions, North America is presumed to lead the global blood glucose test strip market with $ 7.89 billion revenue. The growth is attributed to the extensive use of information technology coupled with high expenditure on healthcare. Moreover, the presence of major medical device manufacturers and high adoption of latest technologies are considered to stimulate the market during the review period.

Europe is estimated to hold the second position in the global market and is likely to maintain its dominance during the review period. High healthcare expenditure led by France and Germany is anticipated to drive the global market.

The Asia Pacific region is presumed to expand at a rapid pace owing to the presence of major regions such as India and China which are expected to lead the market due to unmet needs. This region is presumed to expand at 12.9 % CAGR owing to the growing number of diabetic populations.

Industry Updates

January 2018: Ascensia Diabetes Care has recently announced the expansion of its strategic alliance with the Insulet Corporation which is a leader in tubeless insulin pump technology. The expansion follows the worldwide non-exclusive development agreement that Ascensia had announced in June 2017, to connect its CONTOUR NEXT ONE blood glucose monitoring system with Insulet's next-generation Omnipod System.

Competitive Dashboard

The major players operating the global blood glucose test strip industry are Apex Biotechnology Corp, Shanghai MicroSense, ALL Medicus, Beijing Yicheng Electronics, Elektronika, Nipro Diagnostics, Bayer Diabetes Care, B. Braun, LifeScan, ACON Laboratories, Jiangsu Yuyue, HMD BioMedical Inc., TaiDoc, Betachek National Diagnostics, Roche Diagnostics, i-SENS, Universal Biosensors, Abbott, SANNUO, AgaMatrix Inc, and others.

Brows More Medical Devices Related Market Research Reports:

Clinical Reference Laboratory Market Share Analysis, Size | Industry Trends, 2027

Facial Injectable Market Trends Analysis, Share | Size and Applications, 2023

Healthcare BPO Market Share, Size Analysis | Industry Trends, 2023

About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Market Research Future  

Office No. 528,  

Amanora Chambers Magarpatta Road,  

Hadapsar,  

Pune - 411028  

Maharashtra,

India  

+1 646 845 9312  

Email: sales@marketresearchfuture.com

[strategyr-blog]

The Global Market for Intravenous Equipment is Projected to Reach US$13.2 Billion by 2022

Growing Dependence of Modern Treatment Procedures on IV Drug Therapy to Drive Demand for Intravenous Equipment, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Intravenous Equipment market. The global market for Intravenous Equipment is projected to reach US$13.2 billion by 2022, driven by growing dependence on intravenous drug therapy and need for accurate administration of intravenous fluids in surgical and non-surgical treatment procedures.  

Intravenous equipment is widely used in healthcare settings for accurately delivering nutrients and minerals, fluids, and drugs such as antibiotics, analgesics, and antipyretics to a patient. Technological developments in drug delivery systems, growing incidence of chronic lifestyle disorders and infectious diseases, development of advanced specialty intravenous catheters, use of biocompatible materials to manufacture components of IV systems, represent primary factors driving the importance of IV drug delivery in healthcare facilities. Aging population and increased access to hospice and end-of-life palliative care will continue to drive demand for IV equipment for drug and nutrient infusion. Implementation of a number of government initiatives will also push up adoption of intravenous management of diseases. Rise in cancer, diabetes, gastrointestinal diseases, neurological conditions and malnutrition; increase in healthcare spending and development of healthcare infrastructure represent the other macro drivers influencing market growth, especially in developing countries.  

Intravenous infusion pumps and sets represents the largest as well as the fastest growing product market, with growth governed by technological advancements, adoption of infusion solutions in home care settings, favorable reimbursement coverage, and ongoing transition from conventional insulin pumps to more advanced, tubeless pumps, such as OmniPod to ensure continuous administration of drugs to patients. Intravenous catheters comprising peripheral catheters, midline peripheral catheters, peripherally inserted central catheter, and central venous catheters, is forecast to emerge as the fastest growing market segment. From vascular or arterial line catheters designed to read blood oxygen levels directly from the patient’s arm, to epidural catheters that administer morphine drugs straight into the spinal cord to ease pain, the changing dynamics of intravenous equipment is centered upon improving the patient’s quality of life.

As stated by the new market research report on Intravenous Equipment, the United States represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of 7.3% over the analysis period, led by factors such as growing population and parallel increase in healthcare burden, improving healthcare infrastructure, growing per capita healthcare spending, increased acceptance of IV drug delivery supported by growing awareness over catheter maintenance and the ensuing reduction in catheter-related infections, and increased establishment of alternate care sites such as clinics, home-healthcare, and long-term care facilities.

Major players in the market include AngioDynamics Inc., Arcomed AG, ASCOR S.A., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, C.R. Bard Inc., F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Halyard Health Inc., ICU Medical Inc., Insulet Corp., Medtronic PLC, Moog Inc., Nipro Corporation, Smiths Medical, Tandem Diabetes Care Inc., Teleflex Inc., and Terumo Corp. among others.

The research report titled “Intravenous Equipment: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe) Asia-Pacific (China, and Rest of Asia-Pacific), Latin America and Rest of World. The report analyzes the global and regional markets by the following Product Segments - Intravenous Catheters, and Intravenous Infusion Pumps & Sets.

  For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.          To connect with us, visit our LinkedIn page.

  Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.

[isiawgr-blog]

Global Insulin Pump Market Overview - Key Futuristic Trends and Opportunities

According to a recent study report published by the Market Research Future analysts, the global insulin pump market is growing at a moderate pace; mainly due to the increasing prevalence of diabetes, rise in the obese population, technological advancements in the drug delivery devices, and growing awareness about the diabetes care. Having said that, all is not going well for the insulin pump market. Cost of device is a huge obstacle to greater pump adoption and the cost factor cannot be ignored. Moreover, recent product recalls due to device malfunction have resulted in huge losses for the companies hindering the growth of this market.

Get  a sample report at https://www.marketresearchfuture.com/sample_request/1637 .

Diabetes is a chronic disease, and its global prevalence is increasing immensely. Recently a research study stated that it is one of the foremost causes of death and has increased risk of developing number of serious health problems. According to WHO, in 2008, approximately 347 million people were suffering from diabetes Likewise, according to International Diabetes Federation (IDF) in 2013, approximately 384 million people are suffering from diabetes and approximately 592 million people are expected to suffer by 2035.

Obesity plays a dynamic role in the growth of insulin pumps market. Risk factors of diabetes and high blood pressure are increasing steadily with rise in prevalence of obesity. According to WHO, approximately, 2.8 million people die each year due to obesity and approximately 44% of diabetes cases are attributable to obesity. Trust for America's Health and Robert Wood Johnson Foundation obesity remains one of the biggest fears in the chronic diseases, leading to more than $147 billion to $210 billion dollars in preventable healthcare spending in recent years.

Even though the insulin delivery with pumps, otherwise known as continuous subcutaneous insulin infusion (CSII), was presented almost a half century ago, the major developments in the insulin pump market took place in last couple of decades which changed the therapeutic landscape of diabetes care. Since then,Innovative capabilities have progressed significantly, and pump utilization has increased. In spite of the fact that the pump and its supplies (insulin cartridges, tubing, also, mixture sets) remain costly, insurance coverage has enhanced significantly throughout the years.

Global Insulin Pump Market   - Competitive Analysis

Braun Melsungen AG, F. Hoffmann-La Roche AG, Medtronics, Abbott Laboratories, Becton, Dickinson and Company, Sanofi, Insulet Corporation and Others. are some of the prominent players at the forefront of competition in the global Insulin pump market and are profiled in MRFR Analysis.  

The market of insulin pump consist of number of players that are involved in the development of the insulin pump devices. But only few of them such as Medtronic, and Insulet are able to survive and strive through the tough time for the insulin pumps market.

To acknowledge the reality in this market, Medtronic owns this market at present and considering the present scenario, it will only get bigger. Medtronic has this MiniMed 530G system which is fully integrated with a glucose sensor to give you advanced diabetes control.

Another major company in this segment is Insulet Corporation. The OmniPod may be the only wireless/tubeless system in insulin pump market. However, this system is too expensive which his affecting its larger acceptance.

Browse Complete Report at https://www.marketresearchfuture.com/reports/insulin-pump-market-1637 .

Other than that, Roche has an insulin pump segment but their market presence is lacking. Recently, Roche stoped selling Accu-Chek Insulin Pumps in U.S. So now, there is one less player in the U.S. insulin pump market. But that’s not it, another major company Johnson & Johnson has withdrawn from the insulin pump market. Moreover, Companies like Tandem Diabetes Care, Inc is losing money due to its poor strategies and inefficient business model. But these are not the only problems companies are facing. With the advent of CGM and smart insulin pens, it is strongly believed that optimal control can be achieved as effectively as a pump but cheaper. With expensive costs of the existing insulin pumps, the troubles for the insulin pump companies are growing.

Overall, the options for the consumers in this market are growing slimmer, and one or two companies are benefitted the most from this scenario.

Global Insulin Pump Market - Regional Analysis

The global market for insulin pump is growing gradually. The market is growing with the CAGR of 8.4% during the forecast period from 2016-2023. North America accounts for large market share in 2016. Increasing diabetic population in countries like US and Canada drives more opportunities for insulin pump manufacturers to supply these insulin pumps on huge demand which will boost the revenue for insulin pump market in this region. Moreover, the presence of the biggest player, Medtronic, in U.S. has greatly enhanced the growth of this region in insulin pump market. Moreover, Europe, Asia Pacific region are still believed to be using the old technology insulin pumps for the diabetes care which has maintained their fair share in this market. Middle East & Africa contributes least in the global insulin pump market.

List of Table

TABLE 1 Global Insulin Pump Market, By Types US$ Million (2014-2023)  TABLE 2 Global Traditional Insulin Pump Market Us$ (2014-2023)  TABLE 3 Global Disposable Insulin Pump Market Us$ (2014-2023)  TABLE 4 Global Insulin Pump Market, By End Users US$ Million (2014-2023)  TABLE 5 Global Hospitals & Clinics Market Us$ (2014-2023)  TABLE 6 Global Home Care Market Us$ (2014-2023)  TABLE 7 Global Laboratories Market Us$ (2014-2023)  TABLE 8 Global Insulin Pump Market By Region US$ Million (2014-2023)  TABLE 9 North America Insulin Pump Market By Country US$ Million (2014-2023)  TABLE 10 North America Insulin Pump Market By Types US$ Million (2014-2023)  TABLE 11 North America Insulin Pump Market By End Users US$ Million (2014-2023)  TABLE 12 US Insulin Pump Market By Types US$ Million (2014-2023) 

About Market Research Future:

At Market Research Future (MRFR), We Enable Our Customers To Unravel The Complexity Of Various Industries Through Our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), And Market Research & Consulting Services.

In Order To Stay Updated With Technology And Work Process Of The Industry, MRFR Often Plans & Conducts Meet With The Industry Experts And Industrial Visits For Its Research Analyst Members.

Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India +1 646 845 9312 Email: Salesteam@Marketresearchfuture.Com

[strategyr-blog]

The Global Market for Insulin Pumps (External) is Projected to Reach US$3.9 Billion by 2022

Rise in Insulin Dependent Diabetes Mellitus & Innovation in Insulin Delivery Techniques Drives Demand for External Insulin Pumps, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Insulin Pumps (External) market. The global market for Insulin Pumps (External) is projected to reach US$3.9 billion by 2022, driven by growing prevalence of diabetes, shift towards more convenient solutions for insulin infusion, and technological developments in insulin pumps.

The market for diabetes monitoring and treatment products is transitioning from conventional devices to more advanced versions. From blood glucose meters, insulin syringes and insulin pens, the market is gradually shifting towards less-invasive solutions and devices that enable inter-device communications for more integrated diabetes management and therapy. Devices that are particularly drawing high attention include continuous glucose monitoring, insulin pumps, and systems that combine the two. Growing prevalence of diabetes worldwide and increasing preference for painless insulin delivery have shot up insulin pumps to fame in recent years, driving their adoption. The therapy involves employing a programmable insulin pump, to release insulin from a storage reservoir through a tube to a cannula or needle placed beneath the skin. Insulin pumps automatically deliver a continuous flow of rapid-acting insulin employing background or one or more basal delivery rates. The similarity of insulin pumps to the functioning of pancreas, combined with fewer requirements of syringes, is a major factor attributed to the rising preference of the device as an alternative to the standard multiple daily injections. Aging population, changing lifestyles, increasing obesity rates, growing number of type I diabetics, current lower penetration levels, increasing evidence of effectiveness of insulin pumps in type II diabetics and growing product options are some of the factors driving growth in the market.

Insulin pump technology has been witnessing continuous product advancements. New devices are not only more attractive, lighter, smaller and accurate but also incorporate diabetes management technologies such as blood glucose monitoring (BGM) and continuous glucose monitoring (CGM). Combination of these and other functionality aid in better management of diabetes, thereby drive their demand over competing insulin delivery mechanisms. Other improvements such as increasing convenience in refilling insulin reservoirs with prefilled cartridges, technological advancement in closed loop CGM system, and improvements in materials used and pricing are expected to fuel their adoption. While pumps are more apt for those who find controlling difficult with multiple daily injections, product improvements and benefits would expand their targeted customers well beyond the current primary market. Emergence and growing options in patch pumps is another major factor driving adoption of insulin pumps, which transformed the convenience factor in this space. Recent advances led to development of tubeless pumps, which make them more comfortable for diabetics to wear, fueling adoption of insulin pump technology.

As stated by the new market research report on Insulin Pumps (External), the United States represents the largest market worldwide. As one of the countries with the highest rates of obesity, the United States is home to a large number of diabetes patients. The number of diabetes patients in the country is set to rise, providing improved market prospects for external insulin pump manufacturers. Asia-pacific represents the fastest growing market worldwide, with a CAGR of 10.9% through the analysis period. Led by factors such as growing awareness about cutting edge diabetes management solutions, increasing preference for alternatives to insulin injections, and improving healthcare spending as a result of rising disposable income and easy access to affordable healthcare services, insulin pump market in Asia-pacific is poised to exhibit fastest growth.

Major players profiled in the report include Debiotech S.A., F. Hoffmann-La Roche Ltd., Insulet Corp., Medtronic Plc., Sooil Development Co. Ltd., Tandem Diabetes Care Inc., Valeritas Inc. and Ypsomed Holding AG among others.

The research report titled “Insulin Pumps (External): A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for Insulin Pumps (External) in US$ terms for all major geographic markets such as United States, Canada, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific, Latin America and Rest of World.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.